Journal article · 2020
Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis
Journal of Dermatological Treatment, 31(5), 460–469 · Published 20 March 2020 · DOI 10.1080/09546634.2019.1709612
In brief
“Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis” is a 2020 journal article by Anne M. Rentz and 6 co-authors, published in Journal of Dermatological Treatment. OpenAlex counts 11 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 11
- Most cited in
- 2023 (3)
- Field-weighted impact
- 0.39
- References
- 26
- Authors
- 7
Abstract
Introduction: The primary objective of the study was to evaluate the measurement properties of the patient-reported four-item Psoriasis Symptom Scale (PSS).Methods: Analysis of phase-III data on the efficacy of risankizumab to assess psychometric characteristics of the PSS in patients with moderate-to-severe psoriasis.Results: PSS items had a good range of symptom severity coverage. The PSS had… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rentz, A. M., Skalicky, A. M., Esser, D., Zema, C. L., Becker, K., Bodhani, A. R., & Revicki, D. A. (2020). Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis. Journal of Dermatological Treatment, 31(5), 460–469. https://doi.org/10.1080/09546634.2019.1709612
MLA 9
Rentz, Anne M., et al. “Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis.” Journal of Dermatological Treatment, vol. 31, no. 5, 2020, pp. 460–469. https://doi.org/10.1080/09546634.2019.1709612.
Chicago
Rentz, Anne M., Anne M. Skalicky, Dirk Esser, Carla L. Zema, K. Becker, Amit R. Bodhani, and Dennis A. Revicki. 2020. “Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis.” Journal of Dermatological Treatment 31 (5): 460–469. https://doi.org/10.1080/09546634.2019.1709612.
Harvard
Rentz, A. M. et al. (2020) ‘Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis’, Journal of Dermatological Treatment, 31(5), pp. 460–469. doi:10.1080/09546634.2019.1709612.
IEEE
A. M. Rentz et al., “Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis,” Journal of Dermatological Treatment, vol. 31, no. 5, pp. 460–469, 2020, doi: 10.1080/09546634.2019.1709612.
BibTeX
@article{rentz2020reliability,
title = {{Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis}},
author = {Rentz, Anne M. and Skalicky, Anne M. and Esser, Dirk and Zema, Carla L. and Becker, K. and Bodhani, Amit R. and Revicki, Dennis A.},
journal = {Journal of Dermatological Treatment},
year = {2020},
volume = {31},
number = {5},
pages = {460--469},
doi = {10.1080/09546634.2019.1709612},
url = {https://doi.org/10.1080/09546634.2019.1709612}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2014 | 1 | |
| 2022 | 2 | |
| 2023 | 3 | |
| 2024 | 3 | |
| 2025 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.39: it has been cited 0.39 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- plaque psoriasis
- patient-reported outcomes
- psychometric properties
- test-retest reliability
- known-groups validity
- responsiveness to change
- minimal clinically important difference
- risankizumab
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Rentz, A. M., Skalicky, A. M., Esser, D., Zema, C. L., Becker, K., Bodhani, A. R., & Revicki, D. A. (2020). Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis. Journal of Dermatological Treatment, 31(5), 460–469. https://doi.org/10.1080/09546634.2019.1709612
How many times has this paper been cited?
11 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Anne M. Rentz, Anne M. Skalicky, Dirk Esser, Carla L. Zema, K. Becker, Amit R. Bodhani, Dennis A. Revicki.
What is the DOI of this paper?
10.1080/09546634.2019.1709612, permanently at https://doi.org/10.1080/09546634.2019.1709612. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.